ProQR Therapeutics NV
NASDAQ:PRQR

Watchlist Manager
ProQR Therapeutics NV Logo
ProQR Therapeutics NV
NASDAQ:PRQR
Watchlist
Price: 2.12 USD 1.44%
Market Cap: 223m USD

Intrinsic Value

The intrinsic value of one PRQR stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.12 USD, ProQR Therapeutics NV is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

PRQR Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
ProQR Therapeutics NV

Intrinsic Value History
Dive into the past to invest in the future

PRQR looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether PRQR usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about PRQR?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PRQR valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for ProQR Therapeutics NV.

Explain Valuation
Compare PRQR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PRQR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ProQR Therapeutics NV

Current Assets 111.3m
Cash & Short-Term Investments 106.9m
Receivables 2.5m
Other Current Assets 1.9m
Non-Current Assets 13m
PP&E 13m
Current Liabilities 33.1m
Accounts Payable 305k
Accrued Liabilities 121k
Other Current Liabilities 32.7m
Non-Current Liabilities 34.1m
Long-Term Debt 10m
Other Non-Current Liabilities 24.1m
Efficiency

Free Cash Flow Analysis
ProQR Therapeutics NV

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ProQR Therapeutics NV

Revenue
16.1m EUR
Operating Expenses
-60.5m EUR
Operating Income
-44.4m EUR
Other Expenses
1.9m EUR
Net Income
-42.6m EUR
Fundamental Scores

PRQR Profitability Score
Profitability Due Diligence

ProQR Therapeutics NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Operating Margin is Increasing
Net Margin is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
hidden
Profitability
Score

ProQR Therapeutics NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.

PRQR Solvency Score
Solvency Due Diligence

ProQR Therapeutics NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

ProQR Therapeutics NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PRQR Price Targets Summary
ProQR Therapeutics NV

Wall Street analysts forecast PRQR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRQR is 9.82 USD with a low forecast of 5.05 USD and a high forecast of 14.7 USD.

Lowest
Price Target
5.05 USD
138% Upside
Average
Price Target
9.82 USD
363% Upside
Highest
Price Target
14.7 USD
593% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ProQR Therapeutics NV
does not pay dividends
Shareholder Yield

Current shareholder yield for PRQR is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PRQR stock?

The intrinsic value of one PRQR stock under the Base Case scenario is hidden USD.

Is PRQR stock undervalued or overvalued?

Compared to the current market price of 2.12 USD, ProQR Therapeutics NV is hidden .

Back to Top